Acarbose for treating type 2 diabetes mellitus

Published on 19 Dec 2022
Last Updated on 19 Dec 2022

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has not recommended acarbose for inclusion on the MOH List of Subsidised Drugs for treating type 2 diabetes mellitus due to low clinical need and decreasing utilisation in local practice, unfavourable cost-effectiveness, and availability of multiple subsidised alternatives.

Acarbose for treating type 2 diabetes mellitus (19 December 2022) [PDF, 91 KB]